About: Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1990 (uk) article scientifique publié en 1990 (fr) im August 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1990 (ast) scientific article published on 01 August 1990 (en)
publication date	wds:Q68895200-989C772D-E840-4E77-A6C8-A8C2D04790A2
publication date	1990-08-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q68895200-79BB5F34-1ACF-465F-A3EA-55DB8315312D wds:Q68895200-79E81D92-885B-4030-A012-6A0098FBA718 wds:Q68895200-C84EE279-6B4B-4F7F-BA23-9A1AE16D3E8C wds:Q68895200-CFED78A2-8829-421D-BED7-F24E7C59E55E wds:Q68895200-EC8BB73C-7C73-4BA3-914A-82A593391782
author name string	A A Bartolucci H J Williams J R Ward R E Schrohenloher W J Koopman
rdfs:label	Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression (en) Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression (nl)
skos:prefLabel	Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression (en) Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression (nl)
name	Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression (en) Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression (nl)
author	wds:Q68895200-BB4908E0-A24C-4090-8438-7878388F780B
author	Graciela S Alarcón
title	wds:Q68895200-6065AB59-E3E6-4EC9-9A73-C866870B1EF4
title	Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression (en)
page(s)	wds:Q68895200-551F9E7F-80D1-4C86-8B67-440B511E9651
page(s)	1156-1161
instance of	wds:Q68895200-6655DE4C-13F3-4D98-B320-E6486C0CA444
instance of	scholarly article
main subject	wds:Q68895200-2E8976F3-9C1B-4E18-A08D-1CFD82E69A6A wds:Q68895200-CBF34DC8-60D8-40E2-AC97-40F68BB0AB45
main subject	rheumatoid arthritis wd:Q422232
PubMed ID	wds:Q68895200-667D42D9-0224-4018-98AA-44499506D112
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2390121
PubMed ID	2390121
published in	wds:Q68895200-148543EC-34ED-4F5A-A802-D6D861430B7D
published in	Arthritis and Rheumatism
issue	wds:Q68895200-8CDB8074-2FAC-4C95-B193-D05F097DE161
volume	wds:Q68895200-6A97AA80-CC3C-4035-8352-4A4DF658A792
issue	8
volume	33
DOI	wds:Q68895200-73894227-F7DE-414D-84D0-23F1D693424C
DOI	http://dx.doi.org/10.1002/ART.1780330816
DOI	10.1002/ART.1780330816
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68895200
is cites work of	A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities Does methotrexate increase the risk of infection or malignancy? Somatic mutation and CDR3 lengths of immunoglobulin kappa light chains expressed in patients with rheumatoid arthritis and in normal individuals The mechanism of action of methotrexate Pathogenesis of rheumatoid arthritis. Role of B lymphocytes Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro Disease-modifying antirheumatic drugs. Potential effects in older patients Methotrexate--how does it really work? Molecular action of methotrexate in inflammatory diseases Controlled trial of methotrexate versus 10-deazaaminopterin in the treatment of rheumatoid arthritis Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritis Perioperative use of methotrexate in patients with rheumatoid arthritis undergoing orthopedic surgery Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis Predictive factors in rheumatoid arthritis Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity Bosentan may induce arthritis flare in patients with scleroderma concomitantly treated with methotrexate Cell-type specific response of peripheral blood lymphocytes to methotrexate in the treatment of rheumatoid arthritis Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients One year treatment with low dose methotrexate in rheumatoid arthritis: effect on class specific rheumatoid factors Methotrexate in juvenile rheumatoid arthritis. Do the benefits outweigh the risks? Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study Folate supplementation and methotrexate Immunosuppression in the treatment of disease Pharmacological management of juvenile rheumatoid arthritis Mangosteen ethanol extract alleviated the severity of collagen-induced arthritis in rats and produced synergistic effects with methotrexate
is cites work of	wds:Q34275985-967F1774-DC0A-4AC9-A7FB-A10DE3B2102A wds:Q33567568-DE37EA4B-48A9-417C-97A0-4553F2FD8BB6 wds:Q41696453-74092743-E8C1-4E89-ABF8-D6FA7DDD8E10 wds:Q41757845-26A7FAD9-7C9C-4F25-82BC-4C9B68A1A1CC wds:Q42956045-9465F175-D404-4B36-BFB1-EDB35438D8B0 wds:Q41635846-3D01D3C9-C90A-440D-B1D1-55A20F561244 wds:Q24534771-DB55D4FB-F550-4234-93D7-3D345508F335 wds:Q35752432-3B957348-8156-4E90-ABD3-0B4CBCF72FA2 wds:Q39304368-C2D3FAA0-D547-4921-A4A8-1871EDB4286C wds:Q41208644-8E1ABC00-58AB-457E-B0B4-7A151563D9B0 wds:Q43144564-F1046E64-6477-42D9-AD54-0966D62CCBB8 wds:Q24537702-A7925EF2-45F4-409D-9A69-0FEE6FEB2489 wds:Q38236144-E2336FFD-1A44-4B44-B64A-FAEAC66ACA6B wds:Q43611502-D7995F02-AE74-4562-92E2-301BF18629A2 wds:Q35638652-CC6D4D58-3256-443A-BD8A-2D7D824183B4 wds:Q40736563-D34DA542-243D-42FC-B3B8-AB5490123959 wds:Q40800506-E14A51F7-D5F0-40E7-9B9A-B0C2A196C080 wds:Q59794332-D99E0E79-B775-4230-823F-5938D1F3E00E wds:Q72650153-B02862CC-3678-4CB0-AD35-4B215313B0C6 wds:Q35638299-2BB8329F-080D-46C5-8C2F-F0DE8CD242AB wds:Q38555334-2BF0DCCB-0518-418C-BBEB-DE5FA108F031 wds:Q41635912-DDD19281-7D3E-499C-A908-23B26E9C3708

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software